Checked 2026-11-10. Independent clinical review has not been completed. WADAFUK is independent of WADA and does not provide medical advice or an individual anti-doping determination.
Prohibited in competition
WADA 2026: S6.B, specified, prohibited in competition. The future 2027 List retains this classification. [1] [2]
2026 and 2027 List, S6.B, printed pp.15–16; introductory definitions p.3 · 2026 rules apply from 1 January 2026. Any 2027 material below concerns future rules from 1 January 2027; it is not current clearance.
Nasal-product exposure and harm
FDA’s March 2021 communication concerns abuse or misuse of OTC propylhexedrine nasal inhalers. Reported harms include rapid or abnormal heart rhythms, high blood pressure and paranoia, with some cases resulting in hospitalization or death. [3]
- The evidence includes poison-center calls, case reports and emergency visits. It is not a controlled trial and does not estimate risk during ordinary labeled use.
What remains uncertain
- Educational synthesis only; not individualized medical advice, a TUE decision or a sanction prediction.
Check the sources.
These are concise editorial paraphrases of selected sources, not a systematic review or a reproduction of source tables. Access depth is shown for each reference; an abstract-only check cannot resolve details found only in a full paper.
- WADA 2026 Prohibited List ↗Accessed 2026-11-10 · relevant full-text sections independently opened and inspected
Introduction p.3 · S6 pp.15–16
- WADA 2027 Prohibited List, 4 November revision ↗Accessed 2026-11-10 · relevant full-text sections independently opened and inspected · FUTURE 2027 SOURCE
Introduction p.3 · S6 pp.15–16
- H4. FDA. Propylhexedrine abuse/misuse safety communication, 25 March 2021. ↗Accessed 2026-11-10 · relevant full-text sections independently opened and inspected
Safety communication: findings and harm reports
Check the current official WADA List and the relevant anti-doping authority for your sport, product, route and circumstances. Do not stop or change necessary treatment based on this page. Ask a qualified clinician about health decisions. Missing evidence does not establish safety.